1-3 of 3
inotuzumab ozogamicin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Inotuzumab: from preclinical development to success in B-cell acute lymphoblastic leukemia

Clinical Trials & Observations
Joseph Wynne, David Wright, Wendy Stock
Journal: Blood Advances
Blood Adv (2019) 3 (1): 96–104.
https://doi.org/10.1182/bloodadvances.2018026211
Published: 2019
Journal Articles

Inotuzumab ozogamicin in adults with relapsed or refractory CD22-positive acute lymphoblastic leukemia: a phase 1/2 study

Clinical Trials & Observations
Daniel J. DeAngelo, Wendy Stock, Anthony S. Stein, Andrei Shustov, Michaela Liedtke, Charles A. Schiffer, Erik Vandendries, Katherine Liau, Revathi Ananthakrishnan, Joseph Boni, A. Douglas Laird, Luke Fostvedt, Hagop M. Kantarjian, Anjali S. Advani
Journal: Blood Advances
Blood Adv (2017) 1 (15): 1167–1180.
https://doi.org/10.1182/bloodadvances.2016001925
Published: 2017
Includes: Supplemental data
Journal Articles

Immunotherapy in adult acute lymphoblastic leukemia: the role of monoclonal antibodies

Elias Jabbour, Hagop Kantarjian
Journal: Blood Advances
Blood Adv (2016) 1 (3): 260–264.
https://doi.org/10.1182/bloodadvances.2016000042
Published: 2016